Audit in process? Call the number on your audit letter to get options.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
June 28, 2019 - Pfizer announced the FDA approval of Zirabev (bevacizumab-bvzr), a biosimilar to Genentech’s Avastin® (bevacizumab).
Download PDF
Return to publications
